CRYOPORT, INC. Share-based Payment Arrangement, Expense, Tax Benefit
CRYOPORT, INC. (CYRX) reported Share-based Payment Arrangement, Expense, Tax Benefit of $0 for the 9-month period ending 2012-12-31, per its 10-Q filed 2013-02-14.
Discontinued › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2013-02-14
- CRYOPORT, INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2012-12-31 was $0.00.
- CRYOPORT, INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2012-09-30 was $0.00.
- CRYOPORT, INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2012-06-30 was $0.00.
- CRYOPORT, INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2011-12-31 was $0.00.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month |
|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-14 | $0.00 derived: sum of 2 quarters · filed 2013-02-14 | $0.00 10-Q · filed 2013-02-14 |
| 2012-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-09 | $0.00 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-14 | ||
| 2011-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-14 | $0.00 derived: sum of 2 quarters · filed 2013-02-14 | $0.00 10-Q · filed 2013-02-14 |
| 2011-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-09 | $0.00 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $0.00 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |